| Guardant Health, Inc. | 3.39M | US$509M | 7.4% |
| Immunovant, Inc. | 9.34M | US$360M | 5.2% |
| Vaxcyte, Inc. | 4.3M | US$250M | 3.6% |
| Alnylam Pharmaceuticals, Inc. | 825K | US$248M | 3.6% |
| Veradermics, Incorporated | 2M | US$246M | 3.6% |
| Tarsus Pharmaceuticals, Inc. | 3.67M | US$231M | 3.4% |
| Nuvalent, Inc. | 1.78M | US$220M | 3.2% |
| Ocular Therapeutix, Inc. | 19.7M | US$193M | 2.8% |
| Biomarin Pharmaceutical Inc. | 3.31M | US$189M | 2.8% |
| Nurix Therapeutics, Inc. | 7.74M | US$188M | 2.7% |
| Oruka Therapeutics, Inc. | 1.93M | US$183M | 2.7% |
| Alumis Inc. | 6.35M | US$179M | 2.6% |
| Ionis Pharmaceuticals, Inc. | 2.2M | US$174M | 2.5% |
| Vera Therapeutics, Inc. | 4M | US$172M | 2.5% |
| Axsome Therapeutics, Inc. | 700K | US$171M | 2.5% |
| Genmab A/s | 5.65M | US$155M | 2.3% |
| Hemab Therapeutics Holdings, Inc. | 3.6M | US$132M | 1.9% |
| Tango Therapeutics, Inc. | 4.2M | US$131M | 1.9% |
| Definium Therapeutics, Inc. | 2.75M | US$129M | 1.9% |
| Grail, Inc. | 1.83M | US$125M | 1.8% |
| Bicara Therapeutics Inc. | 4.1M | US$122M | 1.8% |
| Maze Therapeutics, Inc. | 3.73M | US$111M | 1.6% |
| Celldex Therapeutics, Inc. | 2.94M | US$109M | 1.6% |
| Lb Pharmaceuticals Inc | 3.35M | US$109M | 1.6% |
| Mbx Biosciences, Inc. | 1.73M | US$95.6M | 1.4% |
| Cogent Biosciences, Inc. | 2M | US$77.4M | 1.1% |
| Ataibeckley Inc. | 14.4M | US$76M | 1.1% |
| United Therapeutics Corporation | 124K | US$67M | 0.97% |
| Avalo Therapeutics, Inc. | 3.61M | US$66.7M | 0.97% |
| Viridian Therapeutics, Inc. | 3.59M | US$66M | 0.96% |
| Cytokinetics, Incorporated | 700K | US$59.6M | 0.87% |
| Altimmune, Inc. | 19.3M | US$58.5M | 0.85% |
| Personalis, Inc. | 4M | US$53.6M | 0.78% |
| Aclaris Therapeutics, Inc. | 9.35M | US$49.4M | 0.72% |
| Cormedix Inc. | 6.27M | US$49.3M | 0.72% |
| Genedx Holdings Corp. | 700K | US$48.1M | 0.70% |
| Harrow, Inc. | 969K | US$41.2M | 0.60% |
| Corvus Pharmaceuticals, Inc. | 2.49M | US$37.2M | 0.54% |
| Solid Biosciences Inc. | 3.57M | US$35.6M | 0.52% |
| Beam Therapeutics Inc. | 1M | US$34.3M | 0.50% |
| Dyne Therapeutics, Inc. | 1.5M | US$33.3M | 0.48% |
| Immix Biopharma, Inc. | 2.77M | US$28.6M | 0.42% |
| X4 Pharmaceuticals, Inc. | 5.88M | US$27.5M | 0.40% |
| Shattuck Labs, Inc. | 3.71M | US$25.7M | 0.37% |
| Mannkind Corporation | 6M | US$25.6M | 0.37% |
| Century Therapeutics, Inc. | 9.46M | US$23.2M | 0.34% |
| Generate Biomedicines, Inc. | 1.33M | US$22.5M | 0.33% |
| Verastem, Inc. | 5.74M | US$21.9M | 0.32% |
| Kura Oncology, Inc. | 1.98M | US$21.7M | 0.32% |
| Enanta Pharmaceuticals, Inc. | 1.44M | US$21.1M | 0.31% |
| Nektar Therapeutics | 300K | US$20.9M | 0.30% |
| Olema Pharmaceuticals, Inc. | 1.5M | US$18.8M | 0.27% |
| Kailera Therapeutics, Inc. | 700K | US$15.4M | 0.22% |
| Kardigan, Inc. | 600K | US$14.3M | 0.21% |
| Enliven Therapeutics, Inc. | 225K | US$11.4M | 0.17% |
| Promis Neurosciences Inc. | 836K | US$11M | 0.16% |
| Xencor, Inc. | 594K | US$9.56M | 0.14% |
| Context Therapeutics Inc. | 7.42M | US$4.11M | 0.06% |
| Inventiva Sa | 800K | US$3.02M | 0.04% |
| Aligos Therapeutics, Inc. | 444K | US$2.56M | 0.04% |
| Bridgebio Pharma, Inc. | 0 | US$0 | 0.00% |
| Crescent Biopharma, Inc. | 0 | US$0 | 0.00% |
| Cybin, Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |
| Geron Corporation | 0 | US$0 | 0.00% |
| Janux Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Larimar Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ani Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apellis Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Billiontoone, Inc. | 0 | US$0 | 0.00% |